On the other hand, recent study indicated that FBP1 could enter the nucleus and directly inhibit HIF function in a non-catalytic-activity-manner, thus restraining ccRCC progression [12]. The gene discussed is FBP1; the disease is nonpapillary renal cell carcinoma.